VANGUARD GROUP INC - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 14 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$397,000
+52.7%
1,039,148
+495.5%
0.00%–
Q1 2022$260,000
-35.8%
174,500
+4.7%
0.00%–
Q4 2021$405,000–166,600–0.00%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q1 2022.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders